p53 Represses Class Switch Recombination to IgG2a through Its Antioxidant Function
Author(s) -
Jeroen E. J. Guikema,
Carol E. Schrader,
Michael H. Brodsky,
Erin K. Linehan,
Adam Richards,
Nahla El Falaky,
Daniel H. Li,
Hayla K. Sluss,
Eva SzomolanyiTsuda,
Janet Stavnezer
Publication year - 2010
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.0904085
Subject(s) - immunoglobulin class switching , cytidine deaminase , isotype , activation induced (cytidine) deaminase , reactive oxygen species , dna , microbiology and biotechnology , chemistry , biology , antibody , biochemistry , b cell , genetics , monoclonal antibody
Ig class switch recombination (CSR) occurs in activated mature B cells, and causes an exchange of the IgM isotype for IgG, IgE, or IgA isotypes, which increases the effectiveness of the humoral immune response. DNA ds breaks in recombining switch (S) regions, where CSR occurs, are required for recombination. Activation-induced cytidine deaminase initiates DNA ds break formation by deamination of cytosines in S regions. This reaction requires reactive oxygen species (ROS) intermediates, such as hydroxyl radicals. In this study we show that the ROS scavenger N-acetylcysteine inhibits CSR. We also demonstrate that IFN-gamma treatment, which is used to induce IgG2a switching, increases intracellular ROS levels, and activates p53 in switching B cells, and show that p53 inhibits IgG2a class switching through its antioxidant-regulating function. Finally, we show that p53 inhibits DNA breaks and mutations in S regions in B cells undergoing CSR, suggesting that p53 inhibits the activity of activation-induced cytidine deaminase.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom